Your browser doesn't support javascript.
loading
Circulating metabolites are associated with brain atrophy and white matter hyperintensities.
de Leeuw, Francisca A; Karamujic-Comic, Hata; Tijms, Betty M; Peeters, Carel F W; Kester, Maartje I; Scheltens, Philip; Ahmad, Shahzad; Vojinovic, Dina; Adams, Hieab H H; Hankemeier, Thomas; Bos, Daniel; van der Lugt, Aad; Vernooij, Meike W; Ikram, M Arfan; Amin, Najaf; Barkhof, Frederik; Teunissen, Charlotte E; van Duijn, Cornelia M; van der Flier, Wiesje M.
Afiliação
  • de Leeuw FA; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Karamujic-Comic H; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Tijms BM; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Peeters CFW; Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands.
  • Kester MI; Department of Neurology, Flevoziekenhuis, Almere, The Netherlands.
  • Scheltens P; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Ahmad S; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Vojinovic D; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Adams HHH; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Hankemeier T; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Bos D; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van der Lugt A; Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Faculty of Science, Leiden University, Leiden, The Netherlands.
  • Vernooij MW; Translational Epidemiology, Faculty Science, Leiden University, Leiden, The Netherlands.
  • Ikram MA; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Amin N; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Barkhof F; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Teunissen CE; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Duijn CM; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van der Flier WM; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Alzheimers Dement ; 17(2): 205-214, 2021 02.
Article em En | MEDLINE | ID: mdl-32886448
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia / Glicemia / Encéfalo / Doença de Alzheimer / Substância Branca Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia / Glicemia / Encéfalo / Doença de Alzheimer / Substância Branca Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article